SZSE Ticker: 002219

Hengkang Medical Group Co., Ltd.

恒康医疗集团股份有限公司

*ST恒康

HENGKANG MEDICAL

Listing Date: 2008-03-06

Board: SME

Industry Classification: Manufacturing

A-share pharmaceutical companies’ expenses magnifying glass during the period: Shanghai Pharmaceuticals spends 6.2 billion in advertising expenses, and BeiGene invests the most in R&D_Shenzhen Hotline

A-share pharmaceutical companies’ expenses magnifying glass during the period: Shanghai Pharmaceuticals spends 6.2 billion in advertising expenses, and BeiGene invests the most in R&D_Shenzhen Hotline

A-share pharmaceutical company’s expenses magnifying glass during the period: Shanghai Pharmaceuticals spends 6.2 billion advertising expenses, BeiGene invests the most in R&D

What are the exclusive Chinese medicine concept stocks in 2022? Exclusive list and ranking of leading Chinese medicine stocks (stock code)

[V View 2021 Annual Report] In 2021, 60% of pharmaceutical stocks’ revenue and net profit will double, and BeiGene will become the “loss king” – yqqlm

Watching the market: Sunflower Pharmaceuticals stopped in seconds CFi.CN Zhongcai Network

Watching the market: 2 moving averages have a golden cross in the intraday-

Watching the market: Violence in Wuzhong, Jiangsu is rising CFi.CN China Financial Network

Watching the market: 1 share violently pulls up 8 shares and stops in seconds CFi.CN Zhongcai Network

Watching the market: Ai Shida and other 2 stocks stopped in seconds CFi.CN Zhongcai Network

Watching the market: the source of heaven and earth stops in seconds CFi.CN Zhongcai Network

April 25th Shenzhen block trading information_Daily must read_Market Gold Online

33 stocks have the maximum daily limit of 138 million yuan of funds._Oriental Fortune Network

37 stocks closed at daily limit in the morning (with shares) _ Oriental Fortune Net

*ST Hengkang's reorganization plan has been approved by investors and the new milestone will enable the development of the company's main business

Reorganization of new milestones * ST Hengkang was approved to reorganize the investor's commitment to invest 580 million to develop "uniqueness"

Reorganization of new milestones * ST Hengkang was approved to reorganize the investor's commitment to invest 580 million to develop "uniqueness" _ Oriental Fortune Net

Announcement by the administrator of Hengkang Medical Group Co., Ltd. on the court's ruling to approve the reorganization plan

*ST Hengkang (002219.SZ): The court ruled to approve the company's reorganization plan

*ST Hengkang (002219.SZ): The court ruled to approve the company's reorganization plan

*ST Hengkang: The court ruled to approve the company's reorganization plan

Want to see more data? Registered subscribers can see all the data.